General
Spherix Incorporated (the “Company” or “Spherix”), a Delaware corporation, was founded in 1967. The Company’s principal segments are Biospherics, our biotechnology research and development business, and Health Sciences, a technical and regulatory consulting business.
The Company has created two wholly-owned subsidiaries, Biospherics Incorporated and Spherix Consulting, Inc., for its two operating segments. The Company’s Health Sciences contracts are in the name of Spherix Consulting, Inc. and the Company’s patents are in the name of Biospherics Incorporated. Spherix provides management, strategic guidance, business development, marketing and other services to its subsidiaries.
The principal executive offices of the Company are located at 6430 Rockledge Drive, Suite 503, Bethesda, Maryland 20817, and its telephone number is (301) 897-2540.
The Company’s common stock trades on the NASDAQ Capital Market system under the symbol SPEX.
Available Information
Our principal Internet address is www.spherix.com. We make available free of charge on www.spherix.com our annual, quarterly and current reports, and amendments to those reports, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the Securities and Exchange Commission (“SEC”).
Biospherics is dedicated to development of pharmaceuticals. Our strategy to achieve this development is to:
· utilize our clinical development capabilities to manage and drive drug candidates through the clinical development process to approval;
· identify and explore licensing and partnership opportunities for drug candidates;
· seek to acquire medically important drug candidates in early- to mid-stage clinical development; and
· commercialize our drug candidates, either alone or more likely in partnership, which we believe can provide maximum stockholder value.